Since 17-AAG was effective in suppressing MYC mRNA and protein expression while inhibiting tumor cell growth, we validated our results using another geldanamycin derivative, 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17-DMAG). The gene discussed is MYC; the disease is neoplasm.